Evidence map›Paper›PMID 35757309›Full record

ArticleAnnals of medicine and surgery (2012)2022

Zika, Nipah and Kala-azar: Emerging lethal infectious diseases amid COVID-19 as an escalating public health threat in South India.

Utkarsha Uday, Lakshmi Jyothi Tadi, Zarmina Islam, Parvathy Mohanan, Shamas Ghazanfar, Maryam Salma Babar, Sumayya Ismail

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Utkarsha UdayWest Bengal University of Health Sciences, Kolkata, India.
Lakshmi Jyothi TadiDepartment of Microbiology, All India Institute of Medical Sciences, Bibinagar, India.
Zarmina IslamFaculty of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Parvathy MohananFaculty of Medicine, Medical University Sofia, Bulgaria.
Shamas GhazanfarFaculty of Medicine, Medical University Sofia, Bulgaria.
Maryam Salma BabarDubai Medical College for Girls, Dubai, United Arab Emirates.
Sumayya IsmailDubai Medical College for Girls, Dubai, United Arab Emirates.
Dubai Medical College · AEMedical University of Sofia · BGAll India Institute of Medical Sciences · INDow University of Health Sciences · PKWest Bengal University of Health Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As of 6 June 2022, a sum 25,782 of active cases and 524,701 deaths due to Coronavirus disease-19 (COVID-19) have been recorded in India. Stewing in the flares of the pandemic, Kerala is entwined in the wrath of multiple emerging infectious diseases. India, a home to 1.3 billion people, recently faced a devastating second wave of COVID-19 during May of 2021, with a ruckus of chronic shortage of medicine, oxygen supplies, ventilators, besides, being challenged by secondary infections and chronic health ailments. The state of Kerala, alone contributes to 50% COVID-19 caseload, besides, recent simultaneous outbreaks of Zika Virus Disease (ZVD), Nipah Virus Disease (NiVD) and Kala-azar (black fever) on July 8, September 5 and 8, 2021 respectively. Syndemicity and a high case fatality rates of these highly contagious diseases coupled with post infection sequelae, overwhelm the already fragile healthcare system. Thus, these lethal infectious diseases along with an anticipated third wave of COVID-19 pose a serious public health threat in and around South India. With this narrative review, we aim to discuss the challenges that the emergence of intersecting outbreaks of Zika, Nipah, Kala-azar presents with, in the nation, amidst the global pandemic of COVID-19 and provide recommendations so as to help alleviate the situation. The syndemicity of COVID-19 with other infectious diseases, calls for adequate surveillance and monitoring of diseases' outbreaks. To avoid the worst situations like pandemic, the health ministry, public and private health stakeholders in India should strengthen the public healthcare delivery system and providence of quick medical facilities to control the rate of mortality and morbidity during outbreaks.

Indexed as

Black feverBSL-3, biosafety level 3COVID-19COVID-19, Coronavirus disease-19Delta mutantEmerging infectious diseaseGDP, gross domestic productICU, intensive care unitKala-azarnCoV, novel CoronavirusNipahNiVD, Nipah virus diseaseNRHM, national rural health missionNVBDCP, national vector borne disease control programmeOmicronPKDL, post Kala-azar dermal leishmaniasisPPE, personal protective equipmentsSARS-CoV-2, severe acute respiratory syndrome-Coronavirus-2SOP, standard operating proceduresSyndemicityVisceral leishmaniasisVL, Visceral leishmaniasisWHO, world health organizationZikaZVD, Zika virus disease

Identifiers

PMID35757309
PMCPMC9212917
OpenAlexW4282944611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.